BeyondSpring to Participate in the R.W. Baird’s 2023 Global Healthcare Conference
07 Septembre 2023 - 2:00PM
BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”),
a global clinical-stage biopharmaceutical company focused on using
a groundbreaking technology platform for drug discovery and
developing innovative therapies to improve clinical outcomes for
patients with high unmet medical needs, today announced that
management will present and participate in the R.W. Baird’s 2023
Global Healthcare Conference, taking place on September 12 to 13,
2023 in New York City.
The presentation will be accessible on BeyondSpring’s website on
the Events & Presentations page following the conclusion
of the conference.
About BeyondSpringBeyondSpring
(NASDAQ: BYSI) is a global clinical-stage biopharmaceutical company
focused on developing innovative therapies to improve clinical
outcomes for patients with high unmet medical needs. The Company is
advancing its first-in-class lead asset, Plinabulin, as a direct
anti-cancer agent in various cancer indications and to prevent
chemotherapy-induced neutropenia. Its pipeline also includes three
preclinical immuno-oncology assets. Additionally, BeyondSpring’s
subsidiary, SEED Therapeutics, leverages a proprietary targeted
protein degradation (TPD) drug discovery platform and has an
initial R&D collaboration with Eli Lilly. Learn more by
visiting https://beyondspringpharma.com, and follow us on LinkedIn
and Twitter.
Investor
Contact:IR@beyondspringpharma.com
Media
Contact:PR@beyondspringpharma.com
BeyondSpring (NASDAQ:BYSI)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
BeyondSpring (NASDAQ:BYSI)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024